AstraZeneca (AZN) dips on new tax inversion rules

AstraZeneca (NYSE: AZN) shares lurched back 4.3% to $71.45 after the new rules were released. AstraZeneca had been fending off a takeover from Pfizer Inc. Share volume was 228,000, compared to an all-day average of 235,000